Short communication · 12 Aug 2025
Conference abstractPublished 11 Jul 2016
What we should not do in COPD
Maastricht UMC+, Netherlands
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Chronic obstructive pulmonary disease causes signifi cant morbidity and mortality worldwide. Most patients can be treated in primary care. However, even in patients with relatively mild airfl ow obstruction referral to a specialist may lead to important fi ndings, both related to the COPD and to comorbidities. Several classifi cations and grading have been proposed throughout the years that help in categorizing patients, yet not all have direct consequences for the management, that typically includes lifestyle changes of which smoking cessation and increased physical activity or even rehabilitation are paramount and pharmacotherapy. Inhaled medication is aimed at improving expiratory fl ow, reducing hyperinfl ation and infl ammation to slow down disease progression and improve quality of life and prognosis. Long acting bronchodilators have clinically signifi cant eff ects and are widely used, also in mild to moderate disease. In recent years the Asthma COPD Overlap Syndrome has been proposed, which is a misnomer and oft en an excuse to skip an adequate diagnostic process and prescribe triple-therapy in patients who would do well with only one or two diff erent drugs. Unfortunately, the majority of COPD patients are on inhaled steroids but eff ects are small, oft en not clinically relevant and side eff ects such as an increased risk of pneumonia should warrant clinicians to be more prudent in prescribing those. Self management is considered an important component of management strategies, even if eff ects on various outcomes are limited. Repeated lung function measurements are oft en performed both in primary care and in the hospital with limited if any eff ects on management. Taken together, appropriate COPD management is not only about what we should do but certainly also about what we shouldnâÂ?Â?t.
Subjects
Pulmonology & RespiratoryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 12 Aug 2025
Feno: Guiding personalized copd management.
Review article · 12 Aug 2025
Integrated copd care: Cessation, education, digital.
Editorial · 29 Jul 2025
Pulmonary Rehabilitation: Enhancing COPD Life and Function
Opinion · 30 Jun 2025
Personalized COPD Care: Biomarkers, Imaging, and Novel Therapies
More from this journal
The newest in Pulmonary & Respiratory Medicine.
Article · 9 Feb 2026
Magnitude and Associated Factors of Respiratory Distress Syndrome among Preterm Neonate Admitted to Addis Ababa Public Hospital, Ethiopia 2023/24
Commentary · 29 Dec 2025
Evolving IPF: Personalized Therapies, Future Directions
Brief report · 29 Dec 2025
PH/PAH: Advancements, Guidelines, Future Directions
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPulmonary & Respiratory Medicine
- SubjectPulmonology & Respiratory
- BylineArticles whose byline prints “Geertjan Wesseling”

